Humacyte (HUMA) Insider Trading & Ownership $2.47 +0.16 (+6.93%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$2.50 +0.03 (+1.26%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Humacyte (NASDAQ:HUMA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.10%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$138.42KNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$13.48M Get HUMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Humacyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HUMA Insider Buying and Selling by Quarter Humacyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/14/2025William John ScheesseleInsiderBuy6,493$1.54$9,999.22 4/10/2025Dale A SanderCFOBuy20,000$1.53$30,600.00 4/10/2025Shamik J ParikhInsiderBuy7,500$1.55$11,625.00 4/8/2025Kathleen SebeliusDirectorBuy50,000$1.32$66,000.00 12/4/2024Michael T ConstantinoDirectorBuy4,600$4.39$20,194.00 11/20/2024Laura E NiklasonCEOSell261,369$4.40$1,150,023.60 11/19/2024Brady W DouganDirectorSell427,459$4.34$1,855,172.06 11/18/2024Laura E NiklasonCEOSell811,172$4.44$3,601,603.68 9/10/2024Kathleen SebeliusDirectorSell5,182$5.40$27,982.80 9/9/2024Laura E NiklasonCEOSell157,704$5.42$854,755.68 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/29/2024Brady W DouganDirectorSell352,112$6.35$2,235,911.20 8/28/2024Laura E NiklasonCEOSell277,090$6.47$1,792,772.30 8/27/2024Brady W DouganDirectorSell252,676$6.71$1,695,455.96 8/27/2024Dale A SanderCFOSell39,389$6.68$263,118.52 (Data available from 1/1/2013 forward) HUMA Insider Trading Activity - Frequently Asked Questions Who is on Humacyte's Insider Roster? The list of insiders at Humacyte includes Brady W Dougan, Dale A Sander, Gordon M Binder, Heather Ledbetter Prichard, Kathleen Sebelius, Laura E Niklason, Michael T Constantino, Shamik J Parikh, and William John Scheessele. Learn more on insiders at HUMA. What percentage of Humacyte stock is owned by insiders? 5.10% of Humacyte stock is owned by insiders. Learn more on HUMA's insider holdings. Which Humacyte insiders have been buying company stock? The following insiders have purchased HUMA shares in the last 24 months: Brady W Dougan ($14,998.70), Dale A Sander ($30,600.00), Gordon M Binder ($339,000.00), Kathleen Sebelius ($66,000.00), Laura E Niklason ($15,108.50), Michael T Constantino ($20,194.00), Shamik J Parikh ($11,625.00), and William John Scheessele ($9,999.22). How much insider buying is happening at Humacyte? Insiders have purchased a total of 143,005 HUMA shares in the last 24 months for a total of $507,525.42 bought. Which Humacyte insiders have been selling company stock? The following insiders have sold HUMA shares in the last 24 months: Brady W Dougan ($10,006,935.65), Dale A Sander ($263,118.52), Heather Ledbetter Prichard ($1,537,532.04), Kathleen Sebelius ($27,982.80), and Laura E Niklason ($26,044,185.01). How much insider selling is happening at Humacyte? Insiders have sold a total of 8,012,569 Humacyte shares in the last 24 months for a total of $37,879,754.02 sold. Humacyte Key ExecutivesDr. Laura E. Niklason M.D. (Age 61)Ph.D., Founder, President, CEO & Director Compensation: $899.25kMr. Dale A. Sander (Age 64)CFO, Chief Corporate Development Officer & Treasurer Compensation: $704.33k1 recent tradesDr. Heather Ledbetter Prichard Ph.D. (Age 46)Chief Operating Officer Compensation: $647.78kDr. Juliana L. Blum Ph.D.Co-Founder & Executive AdvisorMs. Sabrina OsborneExecutive Vice President of Business Strategy & PeopleMr. William John Scheessele (Age 52)Chief Commercial Officer 1 recent tradesDr. Shamik J. Parikh M.D. (Age 51)Chief Medical Officer Compensation: $514.72kMr. Harold AltersonSenior Vice President of QualityDr. Yang Cao M.D. (Age 58)Ph.D., Chief Regulatory Officer More Insider Trading Tools from MarketBeat Related Companies EWTX Insider Trading TVTX Insider Trading PAHC Insider Trading ABCL Insider Trading HROW Insider Trading WVE Insider Trading AMPH Insider Trading GPCR Insider Trading COGT Insider Trading NTLA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:HUMA) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
